Evidence map›Paper›PMID 31945692›Full record

ArticleHearing research2020

Novel oral multifunctional antioxidant prevents noise-induced hearing loss and hair cell loss.

G D Chen, D M Daszynski, D Ding, H Jiang, T Woolman, K Blessing, P F Kador, R Salvi

Open access · greenAbstract read
In one paragraph

Article in Hearing research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Redox homeostasis dysregulation in noise-induced hearing loss: oxidative stress and antioxidant treatment.Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. [Research progress on antioxidant therapy and prevention in noise- induced hearing loss].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

G D ChenCenter for Hearing and Deafness and Department of Communicative Disorders and Sciences, University at Buffalo, Buffalo, NY, 14214, USA.
D M DaszynskiDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
D DingCenter for Hearing and Deafness and Department of Communicative Disorders and Sciences, University at Buffalo, Buffalo, NY, 14214, USA.
H JiangCenter for Hearing and Deafness and Department of Communicative Disorders and Sciences, University at Buffalo, Buffalo, NY, 14214, USA.
T WoolmanDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
K BlessingDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, 68198, USA; Therapeutic Vision, Inc., Elkhorn, NE, 68022, USA.
P F KadorDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, 68198, USA; Therapeutic Vision, Inc., Elkhorn, NE, 68022, USA.
R SalviCenter for Hearing and Deafness and Department of Communicative Disorders and Sciences, University at Buffalo, Buffalo, NY, 14214, USA. Electronic address: salvi@buffalo.edu.
Nebraska Medical Center · USTherapeutic Vision (United States) · USUniversity of Nebraska Medical Center · US

Funding

Multifunctional Antioxidant to Prevent Noise-Induced Hearing LossR43DC016766 · NIDCD · THERAPEUTIC VISION, INC. · PI KADOR, PETER F · 2018 to 2018
$150k
NIDCD NIH HHS R43 DC016766
6 · The paper itself

Abstract

Oxidative stress is a major contributor to noise-induced hearing loss, the most common cause of hearing loss among military personnel and young adults. HK-2 is a potent, orally-active, multifunctional, redox-modulating drug that has been shown to protect against a wide range of neurological disorders with no observed side effects. HK-2 protected cochlear HEI-OC1 cells against various forms of experimentally-induced oxidative stressors similar to those observed during and after intense noise exposure. The mechanisms by which HK-2 protects cells is twofold, first by its ability to reduce oxidative stress generated by free radicals, and second, by its ability to complex biologically active transition metals such as Fe

Indexed as

Administration, OralAnimalsAntioxidantsCell LineDisease Models, AnimalHair Cells, AuditoryHearingHearing Loss, Noise-InducedOxidative StressRats, Sprague-DawleyReactive Nitrogen SpeciesReactive Oxygen SpeciesAntioxidantsReactive Nitrogen SpeciesReactive Oxygen SpeciesHair cell lossHearing lossNoise exposureOtoprotectionOxidative stress

Identifiers

PMID31945692
PMCPMC7039757
OpenAlexW2997937870

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.